Predictions
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.95
11.11.23
11.11.23
-
11.11.24
11.11.24
-
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.81
05.11.23
05.11.23
-
05.11.24
05.11.24
15.43%
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.01
03.09.23
03.09.23
-
03.09.24
03.09.24
-19.80%
05.11.23
05.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Motus GI Holdings Inc.
Start price
Target price
Perf. (%)
€2.12
24.10.22
24.10.22
€3.00
24.10.23
24.10.23
-73.07%
25.10.23
25.10.23
Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.47
26.09.23
26.09.23
-
26.09.24
26.09.24
-26.87%
15.10.23
15.10.23
Could be very worthwhile Investment >20% year
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€38.99
04.10.23
04.10.23
€22.00
04.10.24
04.10.24
-16.75%
14.10.23
14.10.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Sientra Inc.
Start price
Target price
Perf. (%)
€2.52
25.09.23
25.09.23
€5.20
25.09.24
25.09.24
-23.41%
11.10.23
11.10.23
Could be very worthwhile Investment >20% year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€22.88
14.07.23
14.07.23
€26.00
14.07.24
14.07.24
-22.31%
01.10.23
01.10.23
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.12
27.09.23
27.09.23
-
27.09.24
27.09.24
-35.70%
30.09.23
30.09.23
Risky Investment
Vita 34 AG
Start price
Target price
Perf. (%)
€4.76
19.09.23
19.09.23
€6.00
19.09.24
19.09.24
-1.68%
30.09.23
30.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
MicroVision Inc
Start price
Target price
Perf. (%)
€2.02
19.09.23
19.09.23
€4.00
19.09.24
19.09.24
4.43%
27.09.23
27.09.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Pulse Biosciences Inc
Start price
Target price
Perf. (%)
€4.58
13.04.23
13.04.23
-
13.04.26
13.04.26
-14.85%
26.09.23
26.09.23
Risky Investment
MicroVision Inc
Start price
Target price
Perf. (%)
€3.85
10.07.23
10.07.23
€4.00
10.07.24
10.07.24
-47.53%
19.09.23
19.09.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.79
07.09.23
07.09.23
-
07.09.24
07.09.24
-4.59%
16.09.23
16.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Orpea Nom.
Start price
Target price
Perf. (%)
€1.32
08.09.23
08.09.23
-
08.09.24
08.09.24
10.08%
15.09.23
15.09.23
Could be very worthwhile Investment >20% year
ifa systems AG
Start price
Target price
Perf. (%)
€3.16
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
-5.70%
03.09.23
03.09.23
Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€34.35
22.12.22
22.12.22
-
22.12.23
22.12.23
13.25%
24.08.23
24.08.23
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.28
06.08.23
06.08.23
-
06.08.24
06.08.24
-12.50%
20.08.23
20.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
ShockWave Medical Inc
Start price
Target price
Perf. (%)
€288.60
16.08.22
16.08.22
-
16.08.23
16.08.23
-29.14%
16.08.23
16.08.23
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€157.25
29.07.22
29.07.22
€200.00
29.07.23
29.07.23
14.87%
30.07.23
30.07.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€3.79
27.12.22
27.12.22
-
27.12.23
27.12.23
-90.75%
29.07.23
29.07.23
Capable Management
Risky Investment
No uniques
No Innovation